StockData
Starling Oncology, Inc. logo

Starling Oncology, Inc. (STLNW) stock

STLNWNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLN
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 6/30
$0.03+0.00 (+10.87%)

Close on Oct 30, 2026Market cap $665.51MP/E –Yield –

Starling Oncology market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Starling Oncology's market cap was $649.03M on Oct 19, 2026, against $416.03M a year earlier. Over the last 5 years it ranged from $12.24M to $660.22M, with a median of $151.14M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$649.03M+86.9%
2025Dec 31, 2025$347.35M+1387.7%
2024Dec 31, 2024$23.35M-84.5%
2023Dec 29, 2023$150.41M+26.0%
2022Dec 30, 2022$119.36M-46.8%
2021Dec 31, 2021$224.25M+261.1%
2020Dec 31, 2020$62.10M–

More Starling Oncology figures